Caerus Molecular Diagnostics
Caerus Molecular Explores 'Activator Sequencing' for Long Single-Molecule Reads With Low Error Rates
Premium
The Mountain View, California-based startup is working on proof of concept for the method, which relies on the release of an activator from dNTP that switches on an enzyme.
Companies developing DNA sequencing and related technologies, as well as firms working on sequencing-based genetic tests, were among almost 3,000 small biotechs who received a total of $1 billion in grants and tax credits under the QTDP program.
Several grantees are affiliated with companies working on new commercial sequencing technologies, including GnuBio, Caerus Molecular Diagnostics, Oxford Nanopore Technologies, Intelligent Bio-Systems, NobleGen Biosciences, and Halcyon Molecular.